BUY CHAPTERS

\Drug Safety Solutions and Pharmacovigilance Market Research Report 2022

Code: QYRE-Auto-16F11445

Report

August 2022

Pages:108

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pharmaceutical Product Development LLC

Drug Safety Solutions Limited

C3i

Worldwide Clinical Trials

Bioclinica

United Biosource LLC

Ennov

AB Cube

Covance

Accenture Plc

PRA Health Sciences, Inc.

Ergomed

IQVIA

Genpact Ltd

Cognizant

PAREXEL International Corporation

ArisGlobal

ICON

Oracle

Syneos Health

Drug Safety Solutions and Pharmacovigilance Market Outlook - 2028

The global Drug Safety Solutions and Pharmacovigilance market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Standard Form accounting for % of the Drug Safety Solutions and Pharmacovigilance global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028.

While Biotechnology and Pharmaceuticals segment is altered to an % CAGR throughout this forecast period.

Drug Safety Solutions and Pharmacovigilance Market Insights

Drug safety evaluation, also known as non-clinical drug safety evaluation, refers to the evaluation of the safety of therapeutic drugs through laboratory research and animal in vitro systems. It is a necessary procedure and important step before new drugs enter final clinical trials and final approval. . Drug safety must first be drafted protocols and protocols. These studies, such as general acute chronic toxicity studies, pathohistological studies, reproductive toxicity tests, genotoxicity studies, safety pharmacology studies, investigation studies, and toxicity and safety biomarker studies. Due to the volume of the very successful methods in the Molecular Biology series, the chapters include a brief introduction to the respective disciplines, a list of required materials, a step-by-step, repeatable protocol, and tips on troubleshooting and avoiding known pitfalls.

China Drug Safety Solutions and Pharmacovigilance market size is valued at US$ million in 2021, while the North America and Europe Drug Safety Solutions and Pharmacovigilance are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Drug Safety Solutions and Pharmacovigilance landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Safety Solutions and Pharmacovigilance market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Safety Solutions and Pharmacovigilance market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Safety Solutions and Pharmacovigilance market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Safety Solutions and Pharmacovigilance market.

Drug Safety Solutions and Pharmacovigilance Market Scope and Market Size

Drug Safety Solutions and Pharmacovigilance market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Drug Safety Solutions and Pharmacovigilance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Standard Form
Customized Form

Segment by Application

Biotechnology and Pharmaceuticals
Contract Research Organization (CROS)
Hospital
KPO / BPO
Healthcare Institutions
Others

By Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company

Pharmaceutical Product Development, LLC
Drug Safety Solutions Limited
C3i
Worldwide Clinical Trials
Bioclinica
United Biosource LLC
Ennov
AB Cube
Covance Inc.
Accenture
PRA Health Sciences, Inc.
Ergomed
IQVIA
Genpact
Cognizant
Parexel International Corporation
ArisGlobal
ICON plc
Oracle
Syneos Health

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Standard Form

1.2.3 Customized Form

1.3 Market by Application

1.3.1 Global Drug Safety Solutions and Pharmacovigilance Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Biotechnology and Pharmaceuticals

1.3.3 Contract Research Organization (CROS)

1.3.4 Hospital

1.3.5 KPO / BPO

1.3.6 Healthcare Institutions

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Drug Safety Solutions and Pharmacovigilance Market Perspective (2017-2028)

2.2 Drug Safety Solutions and Pharmacovigilance Growth Trends by Region

2.2.1 Drug Safety Solutions and Pharmacovigilance Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Drug Safety Solutions and Pharmacovigilance Historic Market Size by Region (2017-2022)

2.2.3 Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2023-2028)

2.3 Drug Safety Solutions and Pharmacovigilance Market Dynamics

2.3.1 Drug Safety Solutions and Pharmacovigilance Industry Trends

2.3.2 Drug Safety Solutions and Pharmacovigilance Market Drivers

2.3.3 Drug Safety Solutions and Pharmacovigilance Market Challenges

2.3.4 Drug Safety Solutions and Pharmacovigilance Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue

3.1.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue (2017-2022)

3.1.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Players (2017-2022)

3.2 Global Drug Safety Solutions and Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drug Safety Solutions and Pharmacovigilance Revenue

3.4 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio

3.4.1 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Safety Solutions and Pharmacovigilance Revenue in 2021

3.5 Drug Safety Solutions and Pharmacovigilance Key Players Head office and Area Served

3.6 Key Players Drug Safety Solutions and Pharmacovigilance Product Solution and Service

3.7 Date of Enter into Drug Safety Solutions and Pharmacovigilance Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Type

4.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Type (2017-2022)

4.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2023-2028)

5 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Application

5.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Application (2017-2022)

5.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size (2017-2028)

6.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022)

6.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2017-2028)

7.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022)

7.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size (2017-2028)

8.2 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022)

8.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2017-2028)

9.2 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022)

9.3 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size (2017-2028)

10.2 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022)

10.3 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 Pharmaceutical Product Development, LLC

11.1.1 Pharmaceutical Product Development, LLC Company Detail

11.1.2 Pharmaceutical Product Development, LLC Business Overview

11.1.3 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Introduction

11.1.4 Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.1.5 Pharmaceutical Product Development, LLC Recent Development

11.2 Drug Safety Solutions Limited

11.2.1 Drug Safety Solutions Limited Company Detail

11.2.2 Drug Safety Solutions Limited Business Overview

11.2.3 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Introduction

11.2.4 Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.2.5 Drug Safety Solutions Limited Recent Development

11.3 C3i

11.3.1 C3i Company Detail

11.3.2 C3i Business Overview

11.3.3 C3i Drug Safety Solutions and Pharmacovigilance Introduction

11.3.4 C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.3.5 C3i Recent Development

11.4 Worldwide Clinical Trials

11.4.1 Worldwide Clinical Trials Company Detail

11.4.2 Worldwide Clinical Trials Business Overview

11.4.3 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Introduction

11.4.4 Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.4.5 Worldwide Clinical Trials Recent Development

11.5 Bioclinica

11.5.1 Bioclinica Company Detail

11.5.2 Bioclinica Business Overview

11.5.3 Bioclinica Drug Safety Solutions and Pharmacovigilance Introduction

11.5.4 Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.5.5 Bioclinica Recent Development

11.6 United Biosource LLC

11.6.1 United Biosource LLC Company Detail

11.6.2 United Biosource LLC Business Overview

11.6.3 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Introduction

11.6.4 United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.6.5 United Biosource LLC Recent Development

11.7 Ennov

11.7.1 Ennov Company Detail

11.7.2 Ennov Business Overview

11.7.3 Ennov Drug Safety Solutions and Pharmacovigilance Introduction

11.7.4 Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.7.5 Ennov Recent Development

11.8 AB Cube

11.8.1 AB Cube Company Detail

11.8.2 AB Cube Business Overview

11.8.3 AB Cube Drug Safety Solutions and Pharmacovigilance Introduction

11.8.4 AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.8.5 AB Cube Recent Development

11.9 Covance Inc.

11.9.1 Covance Inc. Company Detail

11.9.2 Covance Inc. Business Overview

11.9.3 Covance Inc. Drug Safety Solutions and Pharmacovigilance Introduction

11.9.4 Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.9.5 Covance Inc. Recent Development

11.10 Accenture

11.10.1 Accenture Company Detail

11.10.2 Accenture Business Overview

11.10.3 Accenture Drug Safety Solutions and Pharmacovigilance Introduction

11.10.4 Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.10.5 Accenture Recent Development

11.11 PRA Health Sciences, Inc.

11.11.1 PRA Health Sciences, Inc. Company Detail

11.11.2 PRA Health Sciences, Inc. Business Overview

11.11.3 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Introduction

11.11.4 PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.11.5 PRA Health Sciences, Inc. Recent Development

11.12 Ergomed

11.12.1 Ergomed Company Detail

11.12.2 Ergomed Business Overview

11.12.3 Ergomed Drug Safety Solutions and Pharmacovigilance Introduction

11.12.4 Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.12.5 Ergomed Recent Development

11.13 IQVIA

11.13.1 IQVIA Company Detail

11.13.2 IQVIA Business Overview

11.13.3 IQVIA Drug Safety Solutions and Pharmacovigilance Introduction

11.13.4 IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.13.5 IQVIA Recent Development

11.14 Genpact

11.14.1 Genpact Company Detail

11.14.2 Genpact Business Overview

11.14.3 Genpact Drug Safety Solutions and Pharmacovigilance Introduction

11.14.4 Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.14.5 Genpact Recent Development

11.15 Cognizant

11.15.1 Cognizant Company Detail

11.15.2 Cognizant Business Overview

11.15.3 Cognizant Drug Safety Solutions and Pharmacovigilance Introduction

11.15.4 Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.15.5 Cognizant Recent Development

11.16 Parexel International Corporation

11.16.1 Parexel International Corporation Company Detail

11.16.2 Parexel International Corporation Business Overview

11.16.3 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Introduction

11.16.4 Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.16.5 Parexel International Corporation Recent Development

11.17 ArisGlobal

11.17.1 ArisGlobal Company Detail

11.17.2 ArisGlobal Business Overview

11.17.3 ArisGlobal Drug Safety Solutions and Pharmacovigilance Introduction

11.17.4 ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.17.5 ArisGlobal Recent Development

11.18 ICON plc

11.18.1 ICON plc Company Detail

11.18.2 ICON plc Business Overview

11.18.3 ICON plc Drug Safety Solutions and Pharmacovigilance Introduction

11.18.4 ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.18.5 ICON plc Recent Development

11.19 Oracle

11.19.1 Oracle Company Detail

11.19.2 Oracle Business Overview

11.19.3 Oracle Drug Safety Solutions and Pharmacovigilance Introduction

11.19.4 Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.19.5 Oracle Recent Development

11.20 Syneos Health

11.20.1 Syneos Health Company Detail

11.20.2 Syneos Health Business Overview

11.20.3 Syneos Health Drug Safety Solutions and Pharmacovigilance Introduction

11.20.4 Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

11.20.5 Syneos Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pharmaceutical Product Development LLC

Drug Safety Solutions Limited

C3i

Worldwide Clinical Trials

Bioclinica

United Biosource LLC

Ennov

AB Cube

Covance

Accenture Plc

PRA Health Sciences, Inc.

Ergomed

IQVIA

Genpact Ltd

Cognizant

PAREXEL International Corporation

ArisGlobal

ICON

Oracle

Syneos Health

List of Tables

Table 1. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

Table 2. Key Players of Standard Form

Table 3. Key Players of Customized Form

Table 4. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

Table 5. Global Drug Safety Solutions and Pharmacovigilance Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Drug Safety Solutions and Pharmacovigilance Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region (2017-2022)

Table 8. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region (2023-2028)

Table 10. Drug Safety Solutions and Pharmacovigilance Market Trends

Table 11. Drug Safety Solutions and Pharmacovigilance Market Drivers

Table 12. Drug Safety Solutions and Pharmacovigilance Market Challenges

Table 13. Drug Safety Solutions and Pharmacovigilance Market Restraints

Table 14. Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players (2017-2022)

Table 16. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2021)

Table 17. Ranking of Global Top Drug Safety Solutions and Pharmacovigilance Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Drug Safety Solutions and Pharmacovigilance Product Solution and Service

Table 21. Date of Enter into Drug Safety Solutions and Pharmacovigilance Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Drug Safety Solutions and Pharmacovigilance Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2017-2022)

Table 25. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2023-2028)

Table 27. Global Drug Safety Solutions and Pharmacovigilance Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application (2017-2022)

Table 29. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application (2023-2028)

Table 31. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022) & (US$ Million)

Table 32. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028) & (US$ Million)

Table 33. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022) & (US$ Million)

Table 34. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028) & (US$ Million)

Table 35. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2017-2022) & (US$ Million)

Table 36. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2023-2028) & (US$ Million)

Table 37. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022) & (US$ Million)

Table 38. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028) & (US$ Million)

Table 39. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2017-2022) & (US$ Million)

Table 40. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2023-2028) & (US$ Million)

Table 41. Pharmaceutical Product Development, LLC Company Detail

Table 42. Pharmaceutical Product Development, LLC Business Overview

Table 43. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Product

Table 44. Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 45. Pharmaceutical Product Development, LLC Recent Development

Table 46. Drug Safety Solutions Limited Company Detail

Table 47. Drug Safety Solutions Limited Business Overview

Table 48. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Product

Table 49. Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 50. Drug Safety Solutions Limited Recent Development

Table 51. C3i Company Detail

Table 52. C3i Business Overview

Table 53. C3i Drug Safety Solutions and Pharmacovigilance Product

Table 54. C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 55. C3i Recent Development

Table 56. Worldwide Clinical Trials Company Detail

Table 57. Worldwide Clinical Trials Business Overview

Table 58. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Product

Table 59. Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 60. Worldwide Clinical Trials Recent Development

Table 61. Bioclinica Company Detail

Table 62. Bioclinica Business Overview

Table 63. Bioclinica Drug Safety Solutions and Pharmacovigilance Product

Table 64. Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 65. Bioclinica Recent Development

Table 66. United Biosource LLC Company Detail

Table 67. United Biosource LLC Business Overview

Table 68. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Product

Table 69. United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 70. United Biosource LLC Recent Development

Table 71. Ennov Company Detail

Table 72. Ennov Business Overview

Table 73. Ennov Drug Safety Solutions and Pharmacovigilance Product

Table 74. Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 75. Ennov Recent Development

Table 76. AB Cube Company Detail

Table 77. AB Cube Business Overview

Table 78. AB Cube Drug Safety Solutions and Pharmacovigilance Product

Table 79. AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 80. AB Cube Recent Development

Table 81. Covance Inc. Company Detail

Table 82. Covance Inc. Business Overview

Table 83. Covance Inc. Drug Safety Solutions and Pharmacovigilance Product

Table 84. Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 85. Covance Inc. Recent Development

Table 86. Accenture Company Detail

Table 87. Accenture Business Overview

Table 88. Accenture Drug Safety Solutions and Pharmacovigilance Product

Table 89. Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 90. Accenture Recent Development

Table 91. PRA Health Sciences, Inc. Company Detail

Table 92. PRA Health Sciences, Inc. Business Overview

Table 93. PRA Health Sciences, Inc. Drug Safety Solutions and PharmacovigilanceProduct

Table 94. PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 95. PRA Health Sciences, Inc. Recent Development

Table 96. Ergomed Company Detail

Table 97. Ergomed Business Overview

Table 98. Ergomed Drug Safety Solutions and PharmacovigilanceProduct

Table 99. Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 100. Ergomed Recent Development

Table 101. IQVIA Company Detail

Table 102. IQVIA Business Overview

Table 103. IQVIA Drug Safety Solutions and PharmacovigilanceProduct

Table 104. IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 105. IQVIA Recent Development

Table 106. Genpact Company Detail

Table 107. Genpact Business Overview

Table 108. Genpact Drug Safety Solutions and PharmacovigilanceProduct

Table 109. Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 110. Genpact Recent Development

Table 111. Cognizant Company Detail

Table 112. Cognizant Business Overview

Table 113. Cognizant Drug Safety Solutions and PharmacovigilanceProduct

Table 114. Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 115. Cognizant Recent Development

Table 116. Parexel International Corporation Company Detail

Table 117. Parexel International Corporation Business Overview

Table 118. Parexel International Corporation Drug Safety Solutions and PharmacovigilanceProduct

Table 119. Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 120. Parexel International Corporation Recent Development

Table 121. ArisGlobal Company Detail

Table 122. ArisGlobal Business Overview

Table 123. ArisGlobal Drug Safety Solutions and PharmacovigilanceProduct

Table 124. ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 125. ArisGlobal Recent Development

Table 126. ICON plc Company Detail

Table 127. ICON plc Business Overview

Table 128. ICON plc Drug Safety Solutions and PharmacovigilanceProduct

Table 129. ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 130. ICON plc Recent Development

Table 131. Oracle Company Detail

Table 132. Oracle Business Overview

Table 133. Oracle Drug Safety Solutions and PharmacovigilanceProduct

Table 134. Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 135. Oracle Recent Development

Table 136. Syneos Health Company Detail

Table 137. Syneos Health Business Overview

Table 138. Syneos Health Drug Safety Solutions and PharmacovigilanceProduct

Table 139. Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2017-2022) & (US$ Million)

Table 140. Syneos Health Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drug Safety Solutions and Pharmacovigilance Market Share by Type: 2021 VS 2028

Figure 2. Standard Form Features

Figure 3. Customized Form Features

Figure 4. Global Drug Safety Solutions and Pharmacovigilance Market Share by Application in 2021 & 2028

Figure 5. Biotechnology and Pharmaceuticals Case Studies

Figure 6. Contract Research Organization (CROS) Case Studies

Figure 7. Hospital Case Studies

Figure 8. KPO / BPO Case Studies

Figure 9. Healthcare Institutions Case Studies

Figure 10. Others Case Studies

Figure 11. Drug Safety Solutions and Pharmacovigilance Report Years Considered

Figure 12. Global Drug Safety Solutions and Pharmacovigilance Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 13. Global Drug Safety Solutions and Pharmacovigilance Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global Drug Safety Solutions and Pharmacovigilance Market Share by Region: 2021 VS 2028

Figure 15. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players in 2021

Figure 16. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2021)

Figure 17. The Top 10 and 5 Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue in 2021

Figure 18. North America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 19. North America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2017-2028)

Figure 20. United States Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Canada Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Europe Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Country (2017-2028)

Figure 24. Germany Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. France Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. U.K. Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. Italy Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Russia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Nordic Countries Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Share by Region (2017-2028)

Figure 32. China Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Japan Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. South Korea Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. India Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. Australia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Latin America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2017-2028)

Figure 40. Mexico Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Brazil Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Share by Country (2017-2028)

Figure 44. Turkey Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 45. Saudi Arabia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 46. Pharmaceutical Product Development, LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 47. Drug Safety Solutions Limited Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 48. C3i Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 49. Worldwide Clinical Trials Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 50. Bioclinica Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 51. United Biosource LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 52. Ennov Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 53. AB Cube Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 54. Covance Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 55. Accenture Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 56. PRA Health Sciences, Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 57. Ergomed Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 58. IQVIA Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 59. Genpact Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 60. Cognizant Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 61. Parexel International Corporation Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 62. ArisGlobal Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 63. ICON plc Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 64. Oracle Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 65. Syneos Health Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2017-2022)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

\Drug Safety Solutions and Pharmacovigilance Market Research Report 2022

Published Date: August 2022

Report Code: QYRE-Auto-16F11445

\Drug Safety Solutions and Pharmacovigilance Market Research Report 2022

FEATURED COMPANIES

Drug Safety Solutions and Pharmacovigilance Market Outlook - 2028

Drug Safety Solutions and Pharmacovigilance Market Insights

Drug Safety Solutions and Pharmacovigilance Market Scope and Market Size

Segment by Type

Segment by Application

By Region

By Company

FEATURED COMPANIES